Search results for "Antivirals"
News on booster doses and omicron, COVID-19 and women's health, outpatient treatments
Recipients of mRNA COVID-19 vaccines are now eligible for boosters at five months, the CDC released additional data on vaccine safety in pregnancy, a study found a short-term association between COVID-19 vaccination and menstrual changes, and new outpatient treatments were authorized.
https://immattersacp.org/weekly/archives/2022/01/11/1.htm
11 Jan 2022
New research analyzes COVID-19 outcomes, testing, and experimental treatments
A retrospective report looked at serologic antibody testing, while two case series reports described use of convalescent plasma in critically ill patients with COVID-19 in China.
https://immattersacp.org/weekly/archives/2020/04/07/2.htm
7 Apr 2020
First device approved to treat congenital heart disease
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2021/05/first-device-approved-to-treat-congenital-heart-disease.htm
1 May 2021
New cardiovascular indication approved for diabetes drug
This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/04/new-cardiovascular-indication-approved-for-diabetes-drug.htm
1 Apr 2022
Latest COVID-19 research on dexamethasone, hydroxychloroquine, a vaccine, tocilizumab
Peer-reviewed details on the recent trial of dexamethasone were released, and two new trials found no benefit to early treatment with hydroxychloroquine. Positive data from a phase 1 vaccine trial were also published, as was another study of tocilizumab.
https://immattersacp.org/weekly/archives/2020/07/21/1.htm
21 Jul 2020
Be proactive about managing hepatitis B
Reports and other guidance on both hepatitis B virus prevention and treatment all have reprised a common theme: Clearly vulnerable individuals are too often missed.
https://immattersacp.org/archives/2018/04/be-proactive-about-managing-hepatitis-b.htm
1 Apr 2018
Recent guidance offered on preparing to treat COVID-19
ACP has developed a new practice management resource on telehealth care in response to the novel coronavirus disease (COVID-19) and continues to press the U.S. government to do more to address the pandemic.
https://immattersacp.org/weekly/archives/2020/03/17/1.htm
17 Mar 2020
Warning on medication confusion, recalls due to sterility
This update covers possible confusion between an antidepressant and an anti-clotting drug, as well as 2 sterility warnings.
https://immattersacp.org/archives/2015/10/fda.htm
1 Oct 2015
HIV and chronic HBV/HCV co-infection may increase non-Hodgkin's lymphoma risk
Co-infected patients with poor immune status or restoration are at high risk for non-Hodgkin's lymphoma and death and deserve high priority for access to well-tolerated, interferon-free, direct-acting antiviral treatment programs, study authors noted.
https://immattersacp.org/weekly/archives/2016/10/18/2.htm
18 Oct 2016
Details on COVID-19 treatments authorized for outpatients
This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/03/details-on-covid-19-treatments-authorized-for-outpatients.htm
1 Mar 2022